Cargando…
Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers
BACKGROUND AND THE PURPOSE OF THE STUDY: Domperidone (DOM) is a dopamine- receptor (D(2)) antagonist, widely used in the treatment of motion-sickness. The pharmacokinetic parameters of DOM make it a suitable candidate for development of Solid Lipid Nanoparticle (SLN) and Nanostructured Lipide Carrie...
Autores principales: | Thatipamula, RP., Palem, CR., Gannu, R., Mudragada, S., Yamsani, MR. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232070/ https://www.ncbi.nlm.nih.gov/pubmed/22615636 |
Ejemplares similares
-
Development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization
por: Madishetti, S.K., et al.
Publicado: (2010) -
In Vitro Studies on Nasal Formulations of Nanostructured Lipid Carriers (NLC) and Solid Lipid Nanoparticles (SLN)
por: Costa, Cláudia Pina, et al.
Publicado: (2021) -
Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications
por: Gokce, Evren H, et al.
Publicado: (2012) -
Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles
por: Elnaggar, Yosra SR, et al.
Publicado: (2011) -
Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review
por: Viegas, Cláudia, et al.
Publicado: (2023)